Cargando…

Causes and Predictors of 30‐Day Readmission in Patients With COVID‐19 and ST‐Segment–Elevation Myocardial Infarction in the United States: A Nationwide Readmission Database Analysis

BACKGROUND: Rates, causes, and predictors of readmission in patients with ST‐segment–elevation myocardial infarction (STEMI) during COVID‐19 pandemic are unknown. METHODS AND RESULTS: All hospitalizations for STEMI were selected from the US Nationwide Readmissions Database 2020 and were stratified b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Kunal N., Majmundar, Monil, Khawaja, Tasveer, Doshi, Rajkumar, Kaur, Avleen, Mehta, Harsh, Gupta, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492991/ https://www.ncbi.nlm.nih.gov/pubmed/37489728 http://dx.doi.org/10.1161/JAHA.123.029738

Ejemplares similares

Impact of Gender, Race, and Insurance Status on Inhospital Management and Outcomes in Patients With COVID-19 and ST-Elevation Myocardial Infarction (a Nationwide Analysis)
por: Patel, Kunal N., et al.
Publicado: (2023)

Sex‐Based Differences in 30‐Day Readmissions After Cardiac Arrest: Analysis of the Nationwide Readmissions Database
por: Sobti, Navjot Kaur, et al.
Publicado: (2022)

MON-LB003 Risk Factors For 30-day Readmission After Diabetic Ketoacidosis Using Nationwide Readmissions Database
por: Varghese, Ron, et al.
Publicado: (2019)

Associations Between Hospital Length of Stay, 30‐Day Readmission, and Costs in ST‐Segment–Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis
por: Jang, Sun‐Joo, et al.
Publicado: (2020)

Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization
por: Majmundar, Monil, et al.
Publicado: (2022)

Percutaneous coronary intervention and 30‐day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database)
por: Sykes, RobertA., et al.
Publicado: (2021)

Outcomes and Predictors of 30-Day Readmissions for Hyperthyroidism: A Nationwide Study
por: Salim, Michael, et al.
Publicado: (2021)

Sex differences in 30-day readmission rates, etiology, and predictors after transcatheter aortic valve replacement
por: Doshi, Rajkumar, et al.
Publicado: (2019)

30-Day Cardiovascular Readmissions Following Discharge With COVID-19: A US Nationwide Readmission Database Analysis From the Pandemic Year 2020
por: Zahid, Salman, et al.
Publicado: (2023)

Right ventricular systolic pressure – Non-invasive bedside predictor of mortality and readmission in heart failure with reduced and preserved ejection fraction hospitalization
por: Majmundar, Monil, et al.
Publicado: (2022)

High Mortality among 30-Day Readmission after Stroke: Predictors and Etiologies of Readmission
por: Nouh, Amre M., et al.
Publicado: (2017)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
por: Yang, Sara, et al.
Publicado: (2022)

Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission
por: Dundon, John, et al.
Publicado: (2023)

Nationwide hospital admission data statistics and disease-specific 30-day readmission prediction
por: Wang, Shuwen, et al.
Publicado: (2022)

OR11-5 Outcomes and Predictors of 30-day Readmission for Hyperthyroidism: A Nationwide Study
por: Adeoti, Oluwatomi, et al.
Publicado: (2022)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
por: Lau, Christine SM, et al.
Publicado: (2017)

“Weekend Effect” on 30-Day Readmissions among Stroke Survivors: An Analysis of the National Readmission Database
por: Khaksari, Bijan J., et al.
Publicado: (2019)

Prognostic Value of Hospital Frailty Risk Score and Clinical Outcomes in Patients Undergoing Revascularization for Critical Limb–Threatening Ischemia
por: Majmundar, Monil, et al.
Publicado: (2023)

Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database
por: Morita, Yusuke, et al.
Publicado: (2019)

B‐Type Natriuretic Peptide Predicts 30‐Day Readmission for Heart Failure but not Readmission for Other Causes
por: Flint, Kelsey M., et al.
Publicado: (2014)

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale
por: Chamberlain, Ronald S, et al.
Publicado: (2018)

Unplanned 30-Day Hospital Readmissions of Symptomatic Carotid and Vertebral Artery Dissection
por: Mehta, Tapan, et al.
Publicado: (2018)

Causes and Predictors of 30‐Day Readmission in Patients With Syncope/Collapse: A Nationwide Cohort Study
por: Kadri, Amer N., et al.
Publicado: (2018)

Characteristics of 30-day readmission in spontaneous pneumothorax in the United States: a nationwide retrospective study
por: Mukhtar, Osama, et al.
Publicado: (2019)

Trends, Predictors, and Outcomes of 30‐Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database
por: Zahid, Salman, et al.
Publicado: (2022)

Determining the Factors Associated With 30- and 90-day Readmissions Following Plastic Surgery Within the National Readmissions Database
por: Sayegh, Farah, et al.
Publicado: (2020)

Examining 30-day COPD readmissions through the emergency department
por: Rezaee, Michael E, et al.
Publicado: (2017)

Paracentesis in cirrhotics is associated with increased risk of 30-day readmission
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

The Impact of Ischaemic Stroke Subtype on 30-day Hospital Readmissions
por: Bjerkreim, Anna Therese, et al.
Publicado: (2018)

Patient vs provider perspectives of 30-day hospital readmissions
por: Smeraglio, Andrea, et al.
Publicado: (2019)

The relationship between diabetes mellitus and 30-day readmission rates
por: Ostling, Stephanie, et al.
Publicado: (2017)

Medication adherence as a predictor of 30-day hospital readmissions
por: Rosen, Olga Z, et al.
Publicado: (2017)

Avoidable 30‐day readmissions in patients undergoing vascular surgery
por: Knighton, A., et al.
Publicado: (2019)

Thirty‐Day Readmission Rates, Timing, Causes, and Costs after ST‐Segment–Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010–2014
por: Kim, Luke K., et al.
Publicado: (2018)

Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
por: Jang, Sun-Joo, et al.
Publicado: (2021)

Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database
por: Jha, Anil Kumar, et al.
Publicado: (2022)

Can we predict early 7-day readmissions using a standard 30-day hospital readmission risk prediction model?
por: Saleh, Sameh N., et al.
Publicado: (2020)

Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study
por: Arora, Sameer, et al.
Publicado: (2020)

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction
por: Majmundar, Monil, et al.
Publicado: (2022)

Contribution of social factors to readmissions within 30 days after hospitalization for COPD exacerbation
por: Goto, Tadahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2s3fqhkn8gt84gvs72ec9tdnrb